---
document_datetime: 2023-09-21 20:05:59
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/harvoni-epar-all-authorised-presentations_en.pdf
document_name: harvoni-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3537628
conversion_datetime: 2025-12-19 23:36:23.965716
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

EU/1/14/958/001 Harvoni 90 mg / 400 mg Film-coated tablet Oral use bottle (HDPE) 28 tablets EU/1/14/958/002 Harvoni 90 mg / 400 mg Film-coated tablet Oral use bottle (HDPE) 84 (3 x 28) tablets EU/1/14/958/003 Harvoni 45 mg / 200 mg Film-coated tablet Oral use bottle (HDPE) 28 tablets EU/1/14/958/004 Harvoni 33.75 mg / 150 mg Coated granules Oral use sachet (PET/alu/PE) 28 sachets EU/1/14/958/005 Harvoni 45 mg / 200 mg Coated granules Oral use sachet (PET/alu/PE) 28 sachets